11-72195423-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 2P and 11B. PM2BP4_ModerateBP6_Very_StrongBP7
The NM_016729.3(FOLR1):c.321C>T(p.Tyr107Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000349 in 1,614,254 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 1 hom. )
Consequence
FOLR1
NM_016729.3 synonymous
NM_016729.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.468
Genes affected
FOLR1 (HGNC:3791): (folate receptor alpha) The protein encoded by this gene is a member of the folate receptor family. Members of this gene family bind folic acid and its reduced derivatives, and transport 5-methyltetrahydrofolate into cells. This gene product is a secreted protein that either anchors to membranes via a glycosyl-phosphatidylinositol linkage or exists in a soluble form. Mutations in this gene have been associated with neurodegeneration due to cerebral folate transport deficiency. Due to the presence of two promoters, multiple transcription start sites, and alternative splicing, multiple transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 11-72195423-C-T is Benign according to our data. Variant chr11-72195423-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 137387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-72195423-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.468 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOLR1 | NM_016729.3 | c.321C>T | p.Tyr107Tyr | synonymous_variant | 2/4 | ENST00000393676.5 | NP_057941.1 | |
FOLR1 | NM_000802.3 | c.321C>T | p.Tyr107Tyr | synonymous_variant | 3/5 | NP_000793.1 | ||
FOLR1 | NM_016724.3 | c.321C>T | p.Tyr107Tyr | synonymous_variant | 4/6 | NP_057936.1 | ||
FOLR1 | NM_016725.3 | c.321C>T | p.Tyr107Tyr | synonymous_variant | 3/5 | NP_057937.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOLR1 | ENST00000393676.5 | c.321C>T | p.Tyr107Tyr | synonymous_variant | 2/4 | 1 | NM_016729.3 | ENSP00000377281.3 |
Frequencies
GnomAD3 genomes AF: 0.00196 AC: 299AN: 152252Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
299
AN:
152252
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000521 AC: 131AN: 251414Hom.: 1 AF XY: 0.000412 AC XY: 56AN XY: 135870
GnomAD3 exomes
AF:
AC:
131
AN:
251414
Hom.:
AF XY:
AC XY:
56
AN XY:
135870
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000181 AC: 265AN: 1461884Hom.: 1 Cov.: 32 AF XY: 0.000160 AC XY: 116AN XY: 727242
GnomAD4 exome
AF:
AC:
265
AN:
1461884
Hom.:
Cov.:
32
AF XY:
AC XY:
116
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00196 AC: 299AN: 152370Hom.: 0 Cov.: 32 AF XY: 0.00188 AC XY: 140AN XY: 74512
GnomAD4 genome
AF:
AC:
299
AN:
152370
Hom.:
Cov.:
32
AF XY:
AC XY:
140
AN XY:
74512
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 01, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 06, 2016 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2017 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Cerebral folate transport deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at